These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20888596)

  • 1. Lymphocyte depletion and repopulation in peripheral blood and small intestine of cynomolgus monkeys after alemtuzumab treatment.
    Shan T; Qu L; Zhang J; Li Q; Shen B; Gu L; Jiang J; Feng X; Li N; Li J
    J Surg Res; 2011 May; 167(1):e21-7. PubMed ID: 20888596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys.
    Van Der Windt DJ; Smetanka C; Macedo C; He J; Lakomy R; Bottino R; Ekser B; Echeverri GJ; Metes D; Ijzermans JNM; Trucco M; Cooper DKC; Lakkis FG
    Am J Transplant; 2010 Apr; 10(4):773-783. PubMed ID: 20420638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys.
    Marco MR; Dons EM; van der Windt DJ; Bhama JK; Lu LT; Zahorchak AF; Lakkis FG; Cooper DK; Ezzelarab MB; Thomson AW
    Transpl Immunol; 2013 Dec; 29(1-4):88-98. PubMed ID: 24120957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia.
    Rezvany MR; Tehrani MJ; Karlsson C; Lundin J; Rabbani H; Osterborg A; Mellstedt H
    Br J Haematol; 2006 Nov; 135(4):475-85. PubMed ID: 16995884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different mechanisms of Campath-1H-mediated depletion for CD4 and CD8 T cells in peripheral blood.
    Lowenstein H; Shah A; Chant A; Khan A
    Transpl Int; 2006 Nov; 19(11):927-36. PubMed ID: 17018129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
    von Kutzleben S; Pryce G; Giovannoni G; Baker D
    Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD52 ligation induces CD4 and CD8 down modulation in vivo and in vitro.
    Shah A; Lowenstein H; Chant A; Khan A
    Transpl Int; 2006 Sep; 19(9):749-58. PubMed ID: 16918536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix.
    Vugmeyster Y; Howell K; Bakshl A; Flores C; Canova-Davis E
    Cytometry A; 2003 Apr; 52(2):101-9. PubMed ID: 12655653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation.
    Meyer RG; Wagner EM; Konur A; Bender K; Schmitt T; Hemmerling J; Wehler D; Hartwig UF; Roosnek E; Huber C; Kolbe K; Herr W
    Bone Marrow Transplant; 2010 Apr; 45(4):668-74. PubMed ID: 19684624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion.
    Silveira FP; Marcos A; Kwak EJ; Husain S; Shapiro R; Thai N; McCurry KR; Abu-Elmagd K; Paterson DL
    J Infect; 2006 Oct; 53(4):241-7. PubMed ID: 16403576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses.
    Anderson AE; Lorenzi AR; Pratt A; Wooldridge T; Diboll J; Hilkens CM; Isaacs JD
    Rheumatology (Oxford); 2012 Aug; 51(8):1397-406. PubMed ID: 22447884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alemtuzumab on neoplastic B cells.
    Golay J; Manganini M; Rambaldi A; Introna M
    Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of tight junctions in intestinal transplantation induced by Campath-1H.
    Li Q; Zhang Q; Wang C; Li Y; Li Y; Li N; Li J; Wu B; Liu X
    Clin Immunol; 2009 Jul; 132(1):141-3. PubMed ID: 19369120
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of alemtuzumab on intestinal intraepithelial lymphocytes and intestinal barrier function in cynomolgus model.
    Qu LL; Lyu YQ; Jiang HT; Shan T; Zhang JB; Li QR; Li JS
    Chin Med J (Engl); 2015 Mar; 128(5):680-6. PubMed ID: 25698204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
    Leandro MJ; Cambridge G; Ehrenstein MR; Edwards JC
    Arthritis Rheum; 2006 Feb; 54(2):613-20. PubMed ID: 16447239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
    Schröder C; Azimzadeh AM; Wu G; Price JO; Atkinson JB; Pierson RN
    Transpl Immunol; 2003; 12(1):19-28. PubMed ID: 14551029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.
    Kanda Y; Oshima K; Kako S; Fukuda T; Uchida N; Miyamura K; Kondo Y; Nakao S; Nagafuji K; Miyamoto T; Kurokawa M; Okoshi Y; Chiba S; Ohashi Y; Takaue Y; Taniguchi S
    Am J Hematol; 2013 Apr; 88(4):294-300. PubMed ID: 23450467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of alemtuzumab on the intestinal Paneth cells and microflora in macaques.
    Li Q; Zhang Q; Wang C; Tang C; Zhang Y; Jiang S; Li N; Li J
    Clin Immunol; 2010 Sep; 136(3):375-86. PubMed ID: 20605528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease.
    Selby WS; Janossy G; Bofill M; Jewell DP
    Clin Exp Immunol; 1983 Apr; 52(1):219-28. PubMed ID: 6345034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodology for isolation and phenotypic characterization of feline small intestinal leukocytes.
    Howard KE; Fisher IL; Dean GA; Jo Burkhard M
    J Immunol Methods; 2005 Jul; 302(1-2):36-53. PubMed ID: 16023664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.